Sumitomo Dainippon Pharma Co. Registered Shares o.N.
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
55.64%
Market Cap
-
P/E Ratio
7.72
Dividend Yield
0.00 %
Earnings per Share
1.54 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 7.566 G | 0 Units |
| PRICE DETERMINATION TIME | 06/04/2026 / 12:01:49 PM | |
| DAILY VOLUME (UNITS) | 140 | |
| DAILY HIGH / LOW | 7.663 | 7.477 |
| PREV. DAY'S PRICE | 7.782 | (06/03) |
| CHANGE DAY BEFORE | -0.22 | -2.78 % |
| 52 WEEK HIGH / LOW | 18.8 (02/19) | 4.82 (06/06) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 1.29 | 1.15 | 1.54 | 0.36 | -5.07 |
| DIVIDENDS PER SHARE | 0.15 | 0.03 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | -100.00 % |
| PRICE - EARNINGS RATIO | 6.79 | 7.61 | 7.72 | 12.25 | - |
| PRICE - BOOK RATIO | - | - | 2.82 | 1.71 | 1.01 |
| PRICE - SALES RATIO | - | - | 1.82 | 0.73 | 0.50 |
| PRICE - CASH FLOW RATIO | - | - | 11.50 | 17.55 | - |
Master Data
| WKN | 858257 |
| ISIN | JP3495000006 |
| SYMBOL | DPM |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Dainippon Sumitomo Pharma |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -3.95 % | -16.56 % | -25.17 % | -44.01 % | 55.64 % | 84.41 % | -50.75 % | -37.74 % |
| HIGH | 8.70 | 9.52 | 12.20 | 18.80 | 18.80 | 18.80 | 18.80 | 18.80 |
| LOW | 7.73 | 7.73 | 7.73 | 7.73 | 4.82 | 1.64 | 1.64 | 7.73 |
Dividend
per share
Company profile
Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.